Ischemic stroke on optimal anticoagulation with novel-oral anticoagulants compared with warfarin.

The article provides comparison of novel-oral anticoagulants with warfarin for treating ischemic stroke patients with nonvalvular atrial fibrillation (NVAF). It reveals the comparison of the lesion pattern, number of atherosclerotic vessels, and the stroke mechanism between strokes. It also mentions the use of novel oral anticoagulant (NOAC) for preventing cardioembolism.